Cardiometabolic risk profile

Biomarker1 paper1 finding

Humans1

Associations

1

VO2max

upin humans1

1 study

VO2max is associated with cardiometabolic risk profile in humans (ΔAIC: 3483 and ΔAIC: 256).
Humansin base and body-size adjusted modelsn = 11,307
A framework for estimating cardiorespiratory fitness from diverse exercise tests · Npj exercise medicine and health · 1 Sep 2026

Latest

9

Frontiers in NutritionReviewYesterday

The gut microbiota-inflammageing axis in cardiometabolic health of older adults and dietary intervention strategies

Microbiome composition

Metabolic Syndrome and Related DisordersHumans21 Sep

Immunometabolic Score AISI, UHR, RDW-to-Triglycerides and LDL-c-to-HDL-c Ratios as Early Markers of Cardiometabolic Risk in a Young Mexican Population with Elevated Waist-to-Height Ratio

Waist-to-height ratio

Npj Exercise Medicine and HealthHumans11 Sep

A framework for estimating cardiorespiratory fitness from diverse exercise tests

Interactive Journal of Medical ResearchHumans10 Sep

Comparative Analysis of Cardiometabolic Risk Profiles Among Hypertensive and Normotensive Adults: Cross-Sectional Study

Research SquareHumansPreprint2 Sep

Association of Obesity and Sarcopenia with Cardiometabolic Outcomes in Older Adults and Sex-Modified Effects: A Study Based on CHARLS

Cardiometabolic disease

European Heart JournalHumans31 Aug

Mapping organ fat distribution and body composition: towards precision profiling of cardiometabolic disease risk

Gut MicrobesReview26 Aug

Sex differences in the gut microbiome and related metabolites: role in cardiometabolic disease

Short-chain fatty acid metabolism

International Journal of ObesityHumans21 Aug

Sexual dimorphism and pro-atherogenic computed tomography radiomic phenotypes of subcutaneous and visceral abdominal fat

AHA Scientific Sessions 2025 AbstractHumans3 Nov

Contemporary Trends in Total and Low-Density Lipoprotein Cholesterol Among Young Adults in the United States, 2005–2024

ADA Scientific Sessions 2025 AbstractHumans13 Jun

BMI Regain and Blood-Pressure Change after Discontinuation of Antiobesity Agents